Existing equipment left visible micro-bubbles in high-viscosity gels, driving unacceptable scrap rates.
Fill-volume variation across batches failed to meet dose uniformity expectations for high-end clinical applications.
Repeated manual intervention created contamination pathways that increasingly conflicted with revised GMP sterile requirements.
Client Profile
Leggenda Solution
Results
Line productivity: Increased by approximately 30% versus legacy filling operation
Regulatory: Successfully passed NMPA on-site inspection; the line now operates as the client's main production line for the product.